🌱 KidneyEnergy.com

← brief for 2026-11-12 · Slowing decline

Treatment-Intensity Associations of Atorvastatin Therapy with Albuminuria and Liver Stiffness in Patients with Type 2 Diabetes and Hyperlipidemia: The ALI-STAR Study

Article C Peer reviewed Observational

Key takeaways

This study looked at people with type 2 diabetes who took a cholesterol drug called atorvastatin. It found a link between the drug and changes in kidney and liver markers. This shows a connection, but it is not proof that the drug caused the change.

Who did this work

Dilan Damla Öztürk · Hilmi Erdem Sümbül (Sağlık Bilimleri Üniversitesi) · Erdinç Gülümsek (Sağlık Bilimleri Üniversitesi) · Çiğdem Erhan (Seyhan Devlet Hastanesi) · Bektaş Işık · Cisem Kizildag · Cahit Dincer · Ahmet Gazi Mustan · İrfan Alişan · Mevlüt Koç (Sağlık Bilimleri Üniversitesi) · Merve Saracoglu Sumbul · Fatih Necip Arıcı

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-11-11
https://doi.org/10.3390/medicina62112204